News related to Dalmane (Flurazepam) and/or conditions it is approved for
Health Tip: Treating Insomnia
Source: MedicineNet Sleep Specialty [2008.11.17]
Title: Health Tip: Treating Insomnia
Category: Health News
Created: 11/15/2008 2:00:00 AM
Last Editorial Review: 11/17/2008
Primary Insomnia Tied to Brain Neurochemical Imbalance
Source: MedicineNet Sleep Aids And Stimulants Specialty [2008.11.04]
Title: Primary Insomnia Tied to Brain Neurochemical Imbalance
Category: Health News
Created: 11/4/2008 2:00:00 AM
Last Editorial Review: 11/4/2008
Primary Insomnia And A Neurochemical Abnormality In Young And Middle-Aged Adults Linked By Study
Source: Sleep / Sleep Disorders / Insomnia News From Medical News Today [2008.11.03]
A study in the Nov. 1 issue of the journal Sleep is the first demonstration of a specific neurochemical abnormality in adults with primary insomnia, providing greater insight to the limited understanding of the condition's pathology. Results indicate that gamma-aminobutyric acid (GABA), the most common inhibitory transmitter in the brain, is reduced by nearly 30 percent in individuals who have been suffering from primary insomnia for more than six months.
Primary Insomnia Tied to Brain Neurochemical Imbalance (HealthDay)
Source: Y! Health News Search RSS Feed [2008.11.03]
HealthDay - MONDAY, Nov. 3 (HealthDay News) -- Adults with primary insomnia have a
specific neurochemical imbalance that makes it more difficult for their
brains to settle down for sleep, a new study says.
Insomnia - EMEA Issues Positive Opinion For LUNIVIA(R) (Eszopiclone) Marketing Authorization Application (MAA) In Europe
Source: Sleep / Sleep Disorders / Insomnia News From Medical News Today [2008.10.26]
Sepracor Inc. (Nasdaq: SEPR) today announced that the EMEA's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending to grant a marketing authorization for LUNIVIA® brand eszopiclone in the European Union (EU) for the treatment of insomnia. The EU labeling provides for patients who require longer-term therapy to be treated for up to six months, with the usual course of therapy for typical patients being short-term. LUNIVIA is marketed in the U.S.
Ten Tips to Avoid Insomnia and Get a Good Night's Sleep
Source: MedicineNet Sleep Aids And Stimulants Specialty [2008.06.05]
Title: Ten Tips to Avoid Insomnia and Get a Good Night's Sleep
Category: Doctor's Views
Created: 6/14/2005
Last Editorial Review: 6/5/2008
The Secret Causes of Insomnia: What Every Woman Should Know About Sleep Problems
Source: MedicineNet Restless Leg Syndrome Specialty [2008.02.20]
Title: The Secret Causes of Insomnia: What Every Woman Should Know About Sleep Problems
Category: Health News
Created: 2/20/2008
Last Editorial Review: 2/20/2008
Insomnia Treatment: Sleep Aids and Stimulants
Source: MedicineNet Narcolepsy Specialty [2007.11.19]
Title: Insomnia Treatment: Sleep Aids and Stimulants
Category: Diseases and Conditions
Created: 9/24/1999 7:06:00 AM
Last Editorial Review: 11/19/2007
Insomnia
Source: MedicineNet Narcolepsy Specialty [2007.04.02]
Title: Insomnia
Category: Diseases and Conditions
Created: 6/6/2005
Last Editorial Review: 4/2/2007
Tiagabine May Be Useful Insomnia Treatment for Adults
Source: Medscape Pharmacotherapy Headlines [2004.06.11]
In a preliminary study, moderate doses of this anticonvulsant drug reduced waking after sleep onset and enhanced deep sleep stages in adults with primary insomnia.
Medscape Medical News
Sleep Centre At Papworth Hospital Seeking Participants For Ethically Approved Sleep Study, England
Source: Clinical Trials / Drug Trials News From Medical News Today [2008.11.26]
Do you have insomnia? The Sleep Centre at Papworth Hospital, a recognised leading sleep research centre, is running an ethically approved sleep study. -- Do you have difficulty sleeping for more than 6.5 hours a night? -- Do you wake-up several times a night? -- Are you aged 18-65? -- Would you like to take part in a clinical study? For more details and an informal discussion call 01480 364168. You will be compensated for your time and travel.
Pycnogenol Cut Jetlag Symptoms In Half For Passengers Taking 7- To 9-hour Flights
Source: Complementary Medicine / Alternative Medicine News From Medical News Today [2008.11.06]
A new study published in the journal of Minerva Cardioangiologica reveals Pycnogenol, pine bark extract from the French maritime pine tree, reduces jetlag in passengers by nearly 50 percent. The two-part study, consisting of a brain CT scan and a scoring system, showed Pycnogenol lowered symptoms of jetlag such as fatigue, headaches, insomnia and brain edema (swelling) in both healthy individuals and hypertensive patients.
New Sleep Medicine Research Presented At CHEST 2008
Source: Sleep / Sleep Disorders / Insomnia News From Medical News Today [2008.10.29]
#6480 INSOMNIA DOES NOT PREDICT HIGH BLOOD PRESSURE Difficulty falling asleep may be associated with a lower risk of hypertension than researchers once believed. Researchers from the University of Kentucky proposed the hypothesis that insomnia would predict hypertension, particularly among African-Americans. Data were analyzed from 1,419 older individuals with a mean age of 73.4 years who were not hypertensive at baseline.
|
